A Review of Drug Abuse, Misuse, and Related Laboratory Challenges

2024-11-1

Amphotericin-B-Induced Chronic Kidney Disease in a Post-COVID-19 Patient with Widespread Rhinocerebral Mucormycosis and Pneumonia: A Case Report

2024-11-1

Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review

2024-11-1

Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures

2024-11-1

Evaluating the Protective Effect of Melatonin on Atorvastatin-induced Mitochondrial Toxicity in Pancreatic Beta Cells

2024-11-1

Unveiling the Latest Breakthroughs: A Comprehensive Review of the Therapeutic Activity and Safety Profile of Aloe vera

2024-11-1

Acknowledgement to Reviewers

2024-11-1

Parsonage-Turner Syndrome Following AstraZeneca COVID-19 Vaccination

2024-9-6

Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A Enzymes

2024-9-4

Tofacitinib-Induced Acute Pancreatitis in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature

2024-9-4

Ciprofloxacin’s Structure Causing Fluoride-Related Toxicity: A Case Report

2024-9-4

Long-Term Use of Metformin and Vitamin B12 Deficiency in Diabetes

2024-8-28

Safety Profile of Mass Administration of Albendazole Among School Children (6-19 Years): A Prospective Active Surveillance Study

2024-8-27

Promoting Patient Engagement in Adverse Drug Reaction Reporting: A Novel Approach Utilizing Set Induction-Based Skill Questionnaires

2024-8-27

Inhibitory Effects of Aspirin and Ibuprofen Overdose on Cholinesterase Activity: In Vivo and In Vitro Studies

2024-8-19

Methimazole-Induced Pancytopenia in a Patient with Graves' Disease: A Case Report and Literature Review

2024-8-2

Pharmacists’ medication reconciliation interventions during admission and transfer from an emergency department at a tertiary care hospital: a randomized pilot study and evaluation of physician and patient perceptions

2024-8-1

Identification of Novel Signals Associated with US-FDA Approved Drugs (2013) Using Disproportionality Analysis

2024-8-1

Interactions between Antimicrobial Peptides and Targets Responsible for their Nephrotoxic Action: Molecular Dynamics Simulations

2024-8-1

An Awareness of Pharmacovigilance among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy

2024-8-1

Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors: Evaluation of Adverse Drug Reaction Reports

2024-8-1

Association of Cardiovascular Events with COVID-19 Vaccines using Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study

2024-8-1

Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients

2024-8-1

Incidence and Severity of Adverse Drug Reactions in Medical Intensive Care Unit

2024-8-1

Navigating Drug-Drug Interactions in Multimorbid Patients: Utilizing Tools, Guidelines, and Clinical Implications

2024-7-26

Posterior Reversible Encephalopathy Syndrome Associated with L-Asparaginase Treatment in Children: Literature Review and Six Case Reports

2024-7-23

A Systematic Review of the Impact of Benzimidazole-based Anthelmintics on Lung Cancer in Animal Models

2024-7-15

Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review

2024-6-20

Drug-induced Tongue Disorders: A Comprehensive Literature Review

2024-5-23

Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review

2024-5-17

Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases

2024-5-17

Herbal Interactions with Cardiac Medications: A Comprehensive Review of Potential Interactions between Herbal Drugs and Commonly Prescribed Cardiac Medications

2024-5-9

Polymeric Micelles as Drug Delivery System: Recent Advances, Approaches, Applications and Patents

2024-5-1

Penicillamine-induced Stevens Johnson Syndrome-toxic Epidermal Necrolysis (SJS-TEN) Overlap in an HIV-infected Patient with Wilson’s Disease and Hepatitis B

2024-5-1

Meet the Section Editor

2024-5-1

Amoxicillin Induced Fever, Rash, and Catatonia - A Case Study

2024-5-1

Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report

2024-5-1

Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines

2024-5-1

Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?

2024-5-1

Multiple Sclerosis Risk Among Anti-tumor Necrosis Factor Alpha Users: A Methodological Review of Observational Studies Based on Real-world Data

2024-5-1

Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report

2024-5-1

Tizanidine Induced Hypotension: Report of a Case and Review of the Literature

2024-5-1

Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites - A Review

2024-5-1

Osimertinib-induced Keratitis and Secondary Toxic Epidermal Necrotic Drug Eruption- A Case Report and Literature Review

2024-5-1

Immediate Reaction to Propranolol: An Extremely Rare but Important Condition. A Case Report

2024-5-1

Concise Review on Scientific Approaches to Burns and Scars

2024-5-1

A Case Report of Cefixime, Paracetamol, and Nimesulide Induced Toxic Epidermal Necrolysis in a Woman with Dengue Infection without any Other Associated Comorbidities

2024-5-1

Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration

2024-5-1

A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction - A Case Report

2024-5-1

The Effect of Renal Replacement Therapy in a Patient with Mercaptopurine Toxicity: Time to Revise Guidelines

2024-5-1